Strides Pharma Science Limited, a global pharmaceutical company headquartered in Bengaluru, India, has achieved a significant milestone by securing an Environmental, Social, and Governance (ESG) score of 76 out of 100 in its debut submission to S&P Global’s Corporate Sustainability Assessment (CSA) 2024. Strides Pharma Excels in S&P Global’s Corporate Sustainability Assessment, placing in the 94th percentile among its peers in the DRG Global Pharmaceuticals industry.
The ESG assessment evaluates companies on their sustainability practices across three dimensions: Environmental, Social, and Governance. Strides Pharma’s performance in these areas is noteworthy:
Social Dimension: The company achieved an impressive score of 85 out of 100, reflecting its strong commitment to human capital management and societal healthcare contributions.
Governance Dimension: With a score of 73 out of 100, Strides demonstrated robust corporate governance practices, underscoring its dedication to ethical business operations and transparency.
Environmental Dimension: The company attained a commendable score of 62 out of 100, highlighting its efforts in environmental stewardship and sustainable operations.
Notably, Strides Pharma Excels in S&P Global’s Corporate Sustainability Assessment by achieving a perfect score in Customer Relations, placing it in the 100th percentile. This reflects the company’s unwavering commitment to exceptional service and fostering strong customer relationships.
Arun Kumar, Founder & Executive Chairperson, and Badree Komandur, MD & Group CEO of Strides Pharma, expressed their pride in this achievement, stating that the industry-leading ESG rating underscores the company’s dedication to responsible business practices and sustainability. They emphasized the company’s ongoing efforts to integrate ESG principles across all operations, aiming to create a lasting, positive impact for all stakeholders.
This recognition is underpinned by key material drivers, including contributions to societal healthcare, human capital management, and corporate governance. These factors have been pivotal in shaping Strides Pharma’s sustainability excellence. The company remains committed to maintaining and further enhancing its ESG performance, striving to set new benchmarks in sustainability and responsible business practices in the years ahead.
Strides Pharma Excels in S&P Global’s Corporate Sustainability Assessment, reinforcing its dedication to integrating sustainability into its core business strategy. By focusing on environmental stewardship, social responsibility, and strong governance, Strides is well-positioned to navigate the evolving global pharmaceutical landscape and contribute positively to the communities it serves.
For more information on Strides Pharma’s innovative product range, visit their product catalog. Additionally, learn more about global sustainability benchmarks from S&P Global’s official site.
#StridesPharma #ESG #Sustainability #SPGlobal #CSA2024 #PharmaceuticalIndustry #CorporateGovernance #EnvironmentalStewardship #SocialResponsibility #InnoglidePharma
